Sorafenib Tablets
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
DLA TROOP SUPPORT
Contract Value
Not provided
Codes & Classification
Solicitation Number
SPE2D2-26-D-0016
NAICS
325412 - Pharmaceutical Preparation Manufacturing
Classification Code
6505
Additional Details
Documents2
The Defense Logistics Agency (DLA) Troop Support, a federal office under the Department of Defense, has issued an award notice for the procurement of Sorafenib Tablets under contract identifier SPE2D2-26-D-0016. This procurement falls within the North American Industry Classification System (NAICS) code 325412, which pertains to Pharmaceutical Preparation Manufacturing, and is further classified under Product Service Code 6505, indicating drugs and biologicals.
The primary purpose of this procurement is to secure a reliable supply of Sorafenib Tablets, a pharmaceutical product used in the treatment of certain types of cancer. The scope of the contract encompasses the manufacturing and delivery of these tablets, ensuring that the Department of Defense has access to high-quality, FDA-compliant medications to support its healthcare requirements. The intended outcome is to maintain continuity in medical support for military personnel and other beneficiaries, with an emphasis on product efficacy, safety, and timely delivery.
Key requirements for this contract include adherence to pharmaceutical manufacturing standards as defined by NAICS 325412, compliance with all applicable federal regulations, and the ability to deliver Sorafenib Tablets in the quantities and specifications outlined by DLA Troop Support. The expected deliverables are the consistent supply of Sorafenib Tablets, meeting all quality and regulatory benchmarks throughout the contract lifecycle.
There are no set-aside requirements for this procurement, indicating that it is open to all qualified suppliers without restrictions for small businesses or other socioeconomic categories. Contractors should note that the opportunity is classified as an award notice, meaning the contract has already been awarded and is currently active.
The contracting entity, DLA Troop Support, is based within the Defense Logistics Agency and serves as the primary point of contact for this procurement. Interested parties or those seeking further information may reach out to the designated contacts: Ryan Guarnere ([email protected], 445-737-1729) and Jason Wray ([email protected], 445-737-6304).
For additional details, including attachments related to the award, contractors can refer to the official notice posted on SAM.gov at https://sam.gov/opp/da762c1d3459427397ea1cdd57fc2287/view.
This summary provides a comprehensive overview of the Sorafenib Tablets procurement, highlighting the contract’s purpose, scope, requirements, and key points of contact, which will remain relevant throughout the contract’s duration.